Skip to main content
. 2021 Jul 31;5(7):ytab285. doi: 10.1093/ehjcr/ytab285
Date
August 2009 Aortic and mitral valvuloplasty due to severe rheumatic stenosis of the aortic and mitral valves.
February 2017 Mechanical valve replacement of aortic and mitral valves.
March 2017 Stop visiting the clinic of patient's own volition due to side effects of warfarin including tingling sensation and numbness of legs, urticaria, skin rash, and nausea.
December 2018 Non-ST-elevation myocardial infarction due to coronary artery embolism. Restart warfarin.
February 2019 Patient complaint of side effects of warfarin such as tingling sensation and numbness of legs, urticaria, and skin rash. Refusal to taking warfarin. Start apixaban 5 mg b.i.d. PO
April 2020 Atrial fibrillation was developed. No prosthetic valve thrombosis or intracardiac thrombi on computed tomography. Successful electrical cardioversion was performed without any thrombo-embolic event.
Until February 2021 No development of major bleeding, stroke, or systemic embolism with apixaban